at Benzinga.com (Dec 22, 2014)
Oncolytics Biotech (ONCY) initiates a public stock offering for an undetermined amount of shares. The company says the size and price of the offering are to be determined at the time of pricing. It intends to use the net proceeds to fund its clinical trial program, manufacturing program and for general corporate and working capital purposes. Shares -7% AH.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Dec 3, 2014)
at Zacks.com (Nov 4, 2014)
at Zacks.com (Oct 30, 2014)
at Fox Business (Sep 9, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs